Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial-MedSci.cn

Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial

Hsu, YC; Chen, CY; Chang, IW; Chang, CY; Wu, CY; Lee, TY; Wu, MS; Bair, MJ; Chen, JJ; Chen, CC; Tseng, CH; Tai, CM; Huang, YT; Ku, WH; Mo, LR; Lin, JT

Lin, JT (corresponding author), China Med Univ Hosp, Digest Med Ctr, Taichung 40447, Taiwan.

LANCET INFECTIOUS DISEASES, 2021; 21 (6): 823

Abstract

Background Antiviral therapy for patients with non-cirrhotic chronic hepatitis B and minimally raised alanine aminotransferase (ALT) is controversial.......

Full Text Link